Insulinoma

Board exam relevance: in 1 of more than 100 exam reports · rank 181
Synonyms
beta cell tumor, islet cell tumor, pancreatic neuroendocrine tumor, pNET, Whipple's triad
Specialty
Internal medicine · Endocrinology & diabetes
Images
Gross specimen 1
Last updated
10/2026 · Dr. Pascal Bafteh
Contents
  1. Images (1)
  2. Definition
  3. Occurrence & epidemiology
  4. Aetiopathogenesis
  5. Clinical features
  6. Diagnosis
  7. Treatment principles
  8. Keep learning in the app
  9. Further reading (open access)
  10. Cross-references

Images (1)

Insulinoma – gross specimen: Gross appearance of an insulinoma: well-circumscribed, reddish-brown, round pancreatic tumorGross specimen
Gross appearance of an insulinoma: well-circumscribed, reddish-brown, round pancreatic tumorImage: Edward Alabraba et al., “Insulinoma” (Wikimedia Commons) · CC BY 2.0 · Source

Definition

Insulinoma is a rare neuroendocrine tumor of the pancreatic beta cells with autonomous, non-suppressible insulin secretion. The hallmark is fasting hypoglycemia; postprandial hypoglycemia occurs less often.

Occurrence & epidemiology

Insulinoma occurs in about 1 in 250,000 people; the median age at diagnosis is about 50 years. Around 10 % of insulinomas occur as part of multiple endocrine neoplasia type 1 (MEN 1); these patients usually develop the disease in their twenties, and the tumors are more often multiple.

Aetiopathogenesis

Insulinomas arise from islet cells. About 80 % are solitary, and only about 10 % are malignant. They are almost always located in the pancreas; in less than 1 % they are found ectopically in the duodenal wall or peripancreatic tissue. The tumor's insulin secretion is not suppressed by falling glucose; accordingly, beta-hydroxybutyrate is low during hypoglycemia.

Clinical features

Hypoglycemia typically occurs in the fasting state. Symptoms often develop insidiously and are easily mistaken for a psychiatric or neurological disorder.

  • Neuroglycopenic symptoms: headache, confusion, visual disturbances, weakness, palsy, ataxia, marked personality changes, loss of consciousness, seizures, coma
  • Sympathetic symptoms with a rapid fall in glucose: faintness, tremor, palpitations, sweating, hunger, nervousness
  • The hyperinsulinism can contribute to weight gain.

Diagnosis

Biochemical confirmation

  • Prolonged fast: because many patients are symptom-free at presentation, a supervised fast of 48–72 hours is performed. About 98 % develop symptoms within 48 hours, 70–80 % within 24 hours.
  • Whipple's triad: symptoms during the fast, simultaneously documented hypoglycemia and relief after carbohydrate intake.
  • Findings during hypoglycemia (glucose < 55 mg/dl or 3.0 mmol/l): inappropriate insulin secretion with a serum level of the hormone > 6 µU/ml (42 pmol/l), C-peptide ≥ 0.6 ng/ml (0.2 nmol/l), proinsulin ≥ 5 pmol/l, low beta-hydroxybutyrate and a rise in glucose after glucagon; screening for oral antidiabetic agents is negative.
  • Distinction from factitious hypoglycemia: with surreptitious use of exogenous hormone, C-peptide and proinsulin are normal or low.

Localization

Localization studies follow only after biochemical confirmation. Endoscopic ultrasound has a sensitivity of more than 90 %; positron emission tomography (PET) can be added. CT has proven of little help in localizing these usually small tumors. Staging follows the TNM system for well-differentiated pancreatic neuroendocrine tumors.

Treatment principles

  • The treatment of choice is surgical removal after preoperative localisation, usually by enucleation or partial pancreatectomy, which is generally curative for benign tumours.
  • Until surgery and in inoperable or metastatic tumours, hypoglycaemia is controlled with frequent meals and drug therapy; in selected cases, somatostatin analogues, mTOR inhibitors, local ablative procedures and peptide receptor radionuclide therapy are options.
  • In young patients or multiple tumours, MEN 1 is investigated.

Specific treatment regimens with drugs and doses are covered in the InnereFuchs app.

Keep learning in the app

In the InnereFuchs app you can learn Insulinoma with flashcards, exam questions and image tasks (ECG, chest X-ray, ultrasound, lab values) – free, in your browser or as an app.

Open in browser  About InnereFuchs →

Further reading (open access)

  1. MSD Manual Professional: Insulinoma
  2. MSD Manual Professional: Hypoglycemia

Cross-references

Keep learning

Keep learning with flashcards, exam questions and spot diagnoses in the InnereFuchs app – free, in your browser or as an app.

Related pages: Type 2 diabetes mellitus · Primary aldosteronism (Conn's syndrome) · Hyperthyroidism

Note: Learning content for medical education – not a treatment recommendation and no substitute for diagnosis or treatment decisions in individual cases. Treatment and management are deliberately not covered on this page.